[The treatment of inflammatory mouth and pharyngeal diseases with Imposit].
D010129:4-Aminobenzoic Acid; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001592:Benzyl Alcohols / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use*; D002594:Cetylpyridinium / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006096:Gramicidin / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D010608:Pharyngeal Diseases / Q000188:drug therapy*; D011726:Pyridinium Compounds / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D001592:Benzyl Alcohols; D001593:Benzyl Compounds; D004338:Drug Combinations; D011726:Pyridinium Compounds; D006096:Gramicidin; C009812:imposit; D002594:Cetylpyridinium; D010129:4-Aminobenzoic Acid
Zur Behandlung entzündlicher Mund- und Rachenraumerkrankungen mit Imposit